Antibiotic Indications: Definition Of “Significant” Remains In FDA’s Hands After Vancocin Ruling

D.C. District Court Judge denies ViroPharma’s request for a preliminary injunction to require FDA to withdraw approval of three ANDAs, says company is unlikely to prevail in its suit challenging agency’s actions.

More from United States

More from North America